Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review

References

• Sethi S. Community-Acquired Pneumonia. Merck Manual. Aug, 23, 2023. Updated Sep 2022. Accessed Aug, 23, 2023. https://www.merckmanuals.com/professional/pulmonary-disorders/pneumonia/community-acquired-pneumonia
   Google Scholar
• Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020;12(1):11. doi: 10.1186/s41479-020-00074-3
   PubMedGoogle Scholar
• Almirall J, Serra-Prat M, Bolíbar I, et al. Risk factors for community-acquired pneumonia in adults: a systematic review of Observational studies. Respiration. 2017;94(3):299–311. doi: 10.1159/000479089
   PubMed Web of Science ®Google Scholar
• Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013 Nov;68(11):1057–1065. doi: 10.1136/thoraxjnl-2013-204282
   PubMed Web of Science ®Google Scholar
• Ewig S, Torres A. Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J. 2011;38(2):253–260. doi: 10.1183/09031936.00199810
   PubMed Web of Science ®Google Scholar
• Bai F, Li X. Comparing several treatments with antibiotics for community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. Iran J Public Health. 2021 Jun;50(6):1108–1119. doi: 10.18502/ijph.v50i6.6410
   PubMed Web of Science ®Google Scholar
• Marshall DC, Goodson RJ, Xu Y, et al. Trends in mortality from pneumonia in the Europe union: a temporal analysis of the European detailed mortality database between 2001 and 2014. Respir Res. May 4 2018;19(1):81. doi: 10.1186/s12931-018-0781-4
   PubMedGoogle Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012 Jan;67(1):71–79. doi: 10.1136/thx.2009.129502
   PubMed Web of Science ®Google Scholar
• Torres A, Blasi F, Peetermans WE, et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1065–1079. doi: 10.1007/s10096-014-2067-1
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technologies in Health. Strings attached: CADTH’s database search filters. Accessed Jan 10, 2020. https://www.cadth.ca/resources/finding-evidence/strings-attached-cadths-database-search-filters
   Google Scholar
• Scottish Intercollegiate Guidelines Network. Search filters. Accessed Jan 10, 2020. https://www.sign.ac.uk/search-filters.html
   Google Scholar
• Wolff E, Storsaeter J, Örtqvist Å, et al. Cost-effectiveness of pneumococcal vaccination for elderly in Sweden. Vaccine. Jul 6 2020;38(32):4988–4995. doi: 10.1016/j.vaccine.2020.05.072
   PubMed Web of Science ®Google Scholar
• Boccalini S, Bechini A, Levi M, et al. Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. Hum Vaccin Immunother. 2013 Mar;9(3):699–706. doi: 10.4161/hv.23268
   PubMed Web of Science ®Google Scholar
• Marbaix S, Peetermans WE, Verhaegen J, et al. Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection. PLoS One. 2018;13(7):e0199427. doi: 10.1371/journal.pone.0199427
   PubMed Web of Science ®Google Scholar
• Kolditz M, Tesch F, Mocke L, et al. Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study. Respir med. 2016 Dec;121:32–38.
   PubMed Web of Science ®Google Scholar
• Kalkowska DA, Boender GJ, Smit LAM, et al. Associations between pneumonia and residential distance to livestock farms over a five-year period in a large population-based study. PLoS One. 2018;13(7):e0200813. doi: 10.1371/journal.pone.0200813
   PubMed Web of Science ®Google Scholar
• Lopez-de-Andres A, Albaladejo-Vicente R, de Miguel-Diez J, et al. Incidence and outcomes of hospitalization for community-acquired, ventilator-associated and non-ventilator hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain. BMJ Open Diabetes Res Care. 2020 Jun;8(1):e001447. doi: 10.1136/bmjdrc-2020-001447
   PubMed Web of Science ®Google Scholar
• Fally M, Israelsen S, Anhøj J, et al. The increasing importance of Haemophilus influenzae in community-acquired pneumonia: results from a Danish cohort study. Infect Dis. 2021 Feb;53(2):122–130. doi: 10.1080/23744235.2020.1846776
   PubMed Web of Science ®Google Scholar
• Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. Apr 1 2016;62(7):817–823. doi: 10.1093/cid/civ1214
   PubMed Web of Science ®Google Scholar
• Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013 Nov;68(11):997–999. doi: 10.1136/thoraxjnl-2013-203384
   PubMed Web of Science ®Google Scholar
• Torner N, Izquierdo C, Soldevila N, et al. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons. Hum Vaccin Immunother. 2017 Feb;13(2):450–455. doi: 10.1080/21645515.2017.1264782
   PubMed Web of Science ®Google Scholar
• EMWvd G, Plouvier BC, HWHA F, et al. Pharmacotherapy within a learning healthcare system: rationale for the Dutch Santeon Farmadatabase. Eur J Hosp Pharm. 2019;26(1):46–50. doi: 10.1136/ejhpharm-2017-001329
   PubMedGoogle Scholar
• Kaier K, Heister T, Götting T, et al. Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital. BMC Infect Dis. Dec 3 2019;19(1):1028. doi: 10.1186/s12879-019-4660-5
   PubMed Web of Science ®Google Scholar
• Walden AP, Clarke GM, McKechnie S, et al. Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care. Apr 1 2014;18(2):R58. doi: 10.1186/cc13812
   PubMed Web of Science ®Google Scholar
• Naoum P, Athanasakis K, Kyriopoulos I, et al. Community acquired pneumonia: a cost-of-illness analysis in Greece. Rural Remote Health. 2020 Jun;20(2):5400. doi: 10.22605/rrh5400
   PubMed Web of Science ®Google Scholar
• Dupuis C, Sabra A, Patrier J, et al. Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs. Crit Care. 2021/1/Oct 2021;25(1):24. doi: 10.1186/s13054-020-03442-z
   PubMed Web of Science ®Google Scholar
• Antunes C, Pereira M, Rodrigues L, et al. Hospitalization direct cost of adults with community-acquired pneumonia in Portugal from 2000 to 2009. Pulmonology. 2020 Sep;26(5):264–267. doi: 10.1016/j.pulmoe.2020.02.013
   PubMed Web of Science ®Google Scholar
• Andrade LF, Saba G, Ricard JD, et al. Health related quality of life in patients with community-acquired pneumococcal pneumonia in France. Health Qual Life Outcomes. Feb 2 2018;16(1):28. doi: 10.1186/s12955-018-0854-6
   PubMedGoogle Scholar
• Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol. 2017 Oct;95:26–35.
   PubMed Web of Science ®Google Scholar
• Torres A, Cillóniz C, Blasi F, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review. Respir med. 2018 Apr;137:6–13.
   PubMed Web of Science ®Google Scholar
• Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020 Apr;37(4):1302–1318. doi: 10.1007/s12325-020-01248-7
   PubMed Web of Science ®Google Scholar
• Lastrucci V, Bonaccorsi G, Forni S, et al. The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in older people: a region-wide population-based study in Tuscany, Italy. Int J Infect Dis. 2021 Aug;109:182–188.
   PubMed Web of Science ®Google Scholar
• Chalmers J, Campling J, Ellsbury G, et al. Community-acquired pneumonia in the United Kingdom: a call to action. Pneumonia (Nathan). 2017;9(1):15. doi: 10.1186/s41479-017-0039-9
   PubMedGoogle Scholar
• Cillóniz C, Dominedò C, Pericàs JM, et al. Community-acquired pneumonia in critically ill very old patients: a growing problem. Eur Respir Rev. Mar 31 2020;29(155). doi: 10.1183/16000617.0126-2019
   PubMed Web of Science ®Google Scholar
• Blanc E, Chaize G, Fievez S, et al. The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia. BMC Infect Dis. Sep 14 2021;21(1):949. doi: 10.1186/s12879-021-06669-5
   PubMed Web of Science ®Google Scholar
• Williams NP, Coombs NA, Johnson MJ, et al. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records. Int J Chron Obstruct Pulmon Dis. 2017;12:313–322. doi: 10.2147/copd.S121389
   PubMed Web of Science ®Google Scholar
• Sheikh D, Tripathi N, Chandler TR, et al. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia. Respir med. 2022 Jan;191:106714.
   PubMed Web of Science ®Google Scholar